Dexlansoprazole MUPS

Product overview

Dexlansoprazole MUPS Pellets – Multiparticulate Platform for Flexible PPI Dosage Forms. Rraynex Dexlansoprazole MUPS Pellets are designed for pharmaceutical manufacturers developing multi-unit pellet systems requiring controlled particle characteristics and gastro-resistant protection. The platform supports flexible dosage-form development while maintaining focus on uniformity, coating integrity, dissolution, and downstream processability. Overview: Dexlansoprazole MUPS formulations use multiple coated units rather than a single monolithic dosage form, allowing flexibility in capsule and other multiparticulate presentations. Rraynex applies controlled pelletization and coating processes to support consistent distribution, moisture management, and release behavior. Key Features & Benefits: • Multi-unit pellet system suitable for PPI formulation development. • Controlled particle-size distribution. • Gastro-resistant coating platform. • Suitable for capsule and multiparticulate dosage forms. • Technical support for formulation optimization and scale-up. Additional Information: Rraynex offers Dexlansoprazole MUPS Pellets, Dexlansoprazole MUPS Manufacturer, Dexlansoprazole MUPS Supplier, Dexlansoprazole Pellets, MUPS Pellets, Multiple Unit Pellet System, PPI Pellets, Proton Pump Inhibitor Pellets, Enteric Coated Pellets, Gastro Resistant Pellets, Delayed Release Pellets, Multiparticulate Pellets, Capsule Filling Pellets, Pharmaceutical Pellets Manufacturer, Bulk Pharmaceutical Pellets, Pharmaceutical Pellet Supplier, GMP Pharmaceutical Manufacturer, CDMO, Pharmaceutical Exporter and Dexlansoprazole Manufacturer India.

Technical & formulation advantages

• Controlled pelletization and coating for reproducible dissolution and downstream handling.
• Uniform particle size and morphology suitable for capsule filling and multiparticulate systems.
• Manufactured under WHO-GMP with in-process controls on assay, moisture and related substances.
• Technical support for formulation development, scale-up and regulatory documentation.

Technical specifications are available upon request.

Applications

• Capsule filling and multiparticulate dosage forms (including MUPS where applicable).
• Pharmaceutical formulation and commercial manufacturing for Anti-Ulcerant (Ppls) therapies.
• CDMO and contract manufacturing programs requiring bulk dexlansoprazole mups.

Bulk pharmaceutical supply & commercial manufacture

Rraynex operates as a pharmaceutical pellets manufacturer and supplier based in India, supporting bulk supply, export and contract manufacturing for Dexlansoprazole MUPS. Supply is available in standard 25/50 kg packaging with batch traceability. Export documentation, DMF/COA access procedures and stability information are provided on request for applicable products.

Contact Rraynex for bulk pellet supply • View manufacturing capabilities

Bulk pharmaceutical supply & product enquiries

Looking to source Dexlansoprazole MUPS in bulk? Rraynex supports pharmaceutical companies seeking Dexlansoprazole MUPS for formulation development, capsule filling and commercial pharmaceutical manufacturing. Buyers can request product specifications, available strengths, technical documentation, samples where applicable, commercial quotations and bulk supply information.

• product specifications
• available strengths
• technical documentation
• samples where applicable
• commercial quotations
• bulk supply information

B2B supply only — not a consumer pharmacy. Pricing available on request for bulk quantities.

Related capabilities

• Pharmaceutical Pellets
• Enteric Coated Pellets
• Sustained Release Pellets
• Modified Release Pellets
• MUPS Pellets
• Contract Manufacturing & CDMO Services
• Contact Sales for Dexlansoprazole MUPS Enquiry

Related products